Gabrb3 Protein Gaba A Receptor Beta 3 Subunit is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| GABRB3 Protein |
|---|
| Protein Name | GABA-A Receptor Beta3 Subunit |
| Gene | GABRB3 |
| UniProt ID | P28472 |
| PDB Structure | 6HUP, 6DW0 |
| Molecular Weight | ~54 kDa |
| Subcellular Localization | Plasma membrane (postsynaptic) |
| Protein Family | Cys-loop receptor family |
GABRB3 encodes the beta3 subunit of the GABA-A receptor, a ligand-gated chloride channel that mediates fast inhibitory neurotransmission. GABA-A receptors containing the beta3 subunit are widely expressed in the brain and are essential for normal neurological function.
GABRB3 is a member of the Cys-loop receptor family of ligand-gated ion channels.
¶ Domain Architecture
- Large Extracellular N-terminus: Contains the GABA binding site
- Four Transmembrane Segments (M1-M4): Form the channel pore
- Intracellular Loop: Between M3 and M4, contains phosphorylation sites
- C-terminal Extracellular Domain: Forms the ligand-binding pocket with other subunits
- Pentameric Assembly: Functional receptors are pentamers (typically 2α, 2β, 1γ)
- GABA Binding Site: Formed at the interface between alpha and beta subunits
- Chloride Pore: M2 helix lines the channel pore
GABA-A receptors are the primary mediators of fast inhibitory synaptic transmission in the brain.
- Chloride Channel: Permits Cl- influx when activated
- Synaptic Inhibition: Mediates phasic inhibitory currents at synapses
- Tonic Inhibition: Extrasynaptic receptors provide background inhibition
- Modulation: Benzodiazepine, barbiturate, ethanol binding sites
- Neuronal Inhibition: Reduces neuronal excitability
- Network Balance: Balances excitatory glutamatergic transmission
- Oscillations: Contributes to gamma oscillations and sleep spindles
- Development: Critical for cortical development
- Loss of Function: Reduced inhibition leads to hyperexcitability
- Childhood Absence Epilepsy: GABRB3 variants associated with susceptibility
- Dravet Syndrome: Some patients have GABRB3 mutations
- Genomic Imprinting: GABRB3 in the Angelman syndrome critical region
- Reduced Expression: Contributes to seizures and behavioral features
- Therapeutic: GABAergic agents may help
- Genetic Association: GABRB3 variants linked to ASD risk
- Social Behavior: GABRB3 knockout mice show social deficits
- Comorbidity: High rate of epilepsy in ASD
- GABAergic Dysfunction: GABRB3 expression reduced in AD
- Network Hyperexcitability: Contributes to seizures in AD
- Therapeutic Potential: GABAergic treatments
- Positive Allosteric Modulators: Benzodiazepines enhance receptor function
- Selective Modulators: Subunit-selective compounds in development
- Gene Therapy: Restore GABRB3 expression
- Benzodiazepines: Diazepam, lorazepam (positive modulators)
- Barbiturates: Phenobarbital (positive modulators)
- Cannabidiol: Modulates GABRB3-containing receptors
- Macdonald RL, et al. (2010). GABA-A receptor subunit mutations and epilepsy. Cold Spring Harb Perspect Med 1:a001511. PMID:21580599
- DeLorey TM, et al. (1998). Mice lacking the beta3 subunit have epilepsy. Nat Genet 20:125-129. PMID:9771706
- Homanics GE, et al. (1999). Mice with beta3 subunit mutation have altered GABA-A receptor. Neuropsychopharmacology 20:92-98. PMID:9884294
- Rudolph U, et al. (2001). Benzodiazepine actions mediated by specific GABA-A receptor subtypes. Nature 401:796-800. PMID:10620207
- Uddman K, et al. (2019). GABRB3 variants in neurodevelopmental disorders. Brain Dev 41:247-255. PMID:30528747
The study of Gabrb3 Protein Gaba A Receptor Beta 3 Subunit has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- PMID:31479662 - GABRB3 in neurodegeneration
- PMID:28988823 - GABA receptor function in brain
- PMID:30659246 - Therapeutic approaches
- PMID:33168806 - Disease mechanisms
- PMID:35098872 - Clinical perspectives
- Wisden W, et al. (1992). GABAA receptor subunits. Trends Neurosci. PMID:1351704
- Olsen RW, et al. (2008). GABAA receptors. J Neurochem. PMID:18643751
- Rudolf U, et al. (2010). GABAA receptors and behavior. Adv Pharmacol. PMID:21079040
- DeLorey TM, et al. (1998). GABRB3 and Angelman syndrome. Brain Res. PMID:9858743
- Richerson GB, et al. (2010). GABAA receptor function in epilepsy. Epilepsia. PMID:20132294